Biogen Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€131.80
Target price
31.10.26
€181.48
Performance (%)
21.09%
Price
13:58
€159.60
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 21.09%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.924% | -0.924% |
| iShares Core DAX® | -0,44 % | -5,31 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % |
| iShares S&P 500 | -0,42 % | 0,92 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $217.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat